Skip to content

EU · EudraLex Vol.4

EU GMP Annex 1 8.85

8. Production and Specific Technologies › Filter sterilisation of products which cannot be sterilised in their final container

Section text

Filtration parameters that should be considered and established during validation should include, but are not limited to:

i. The wetting fluid used for filter integrity testing:

• It should be based on the filter manufacturer’s recommendation or the fluid to be filtered. The appropriate integrity test value specification should be established.

• If the system is flushed or integrity tested in-situ with a fluid other than the product, appropriate actions are taken to avoid any deleterious effect on product quality.

ii. Filtration process conditions including:

• Fluid pre-filtration holding time and effect on bioburden.

• Filter conditioning, with fluid if necessary.

• Maximum filtration time/total time filter is in contact with the fluid.

• Maximum operating pressure.

• Flow rate.

• Maximum filtration volume.

• Temperature.

• The time taken to filter a known volume of bulk solution and the pressure difference to be used across the filter.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.